Synopsis
Synopsis
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. 4-(ethyl-(4-methoxy-alpha-methylphenethyl)aminobutyl) Veratrate
2. Duspatalin
3. Mebeverine
4. Spasmotalin
1. 2753-45-9
2. Mebeverine Hcl
3. Duspatalin
4. Colofac
5. Csag-144
6. Csag 144
7. Mebeverine Hydrochloride [usan]
8. Mebeverine (hydrochloride)
9. Nsc-169101
10. 15vz5al4jn
11. 4-[ethyl-[1-(4-methoxyphenyl)propan-2-yl]amino]butyl 3,4-dimethoxybenzoate;hydrochloride
12. Mls000028652
13. Duspatal
14. Benzoic Acid, 3,4-dimethoxy-, 4-(ethyl(2-(4-methoxyphenyl)-1-methylethyl)amino)butyl Ester, Hydrochloride
15. Rudakol
16. Smr000058862
17. Dsstox_cid_25372
18. Dsstox_rid_80834
19. Dsstox_gsid_45372
20. Mebeverine Hydrochloride (usan)
21. 4-(ethyl(1-(4-methoxyphenyl)propan-2-yl)amino)butyl 3,4-dimethoxybenzoate Hydrochloride
22. 4-{ethyl[2-(4-methoxyphenyl)-1-methylethyl]amino}butyl 3,4-dimethoxybenzoate Hydrochloride
23. Nsc 169101
24. Nsc169101
25. Einecs 220-400-0
26. Unii-15vz5al4jn
27. Sr-01000003159
28. 4-(ethyl(p-methoxy-.alpha.-methylphenethyl)amino)butyl Veratrate Hydrochloride
29. 4-[ethyl(p-methoxy-.alpha.-methylphenethyl)amino]butyl Veratrate Hydrochloride
30. Prestwick_587
31. Mebeverine D6 Hcl
32. Colofac Hydrochloride
33. Duspatal Hydrochloride
34. Duspatalin Hydrochloride
35. Opera_id_1589
36. Ncgc00016617-01
37. 4-(ethyl(p-methoxy-alpha-methylphenethyl)amino)butyl Veratrate Hydrochloride
38. Cas-2753-45-9
39. Mls001148590
40. Mls002222299
41. Schembl121977
42. Spectrum1501117
43. Regid_for_cid_17683
44. Chembl1446650
45. Dtxsid1045372
46. Hms1568n22
47. Hms1921f15
48. Pharmakon1600-01501117
49. Bcp28149
50. Ex-a4568
51. Hy-a0078
52. Tox21_110527
53. Ccg-39022
54. Mebeverine Hydrochloride [mi]
55. Mfcd00083411
56. Nsc757840
57. S5027
58. Akos027420570
59. Tox21_110527_1
60. Cs-6931
61. Nsc-757840
62. 4-[ethyl-[1-(4-methoxyphenyl)propan-2-yl]amino]butyl 3,4-dimethoxybenzoate Hydrochloride
63. Mebeverine Hydrochloride [mart.]
64. Veratric Acid, 4-(ethyl(p-methoxy-alpha-methylphenethyl)amino)butyl Ester, Hydrochloride
65. Mebeverine Hydrochloride [who-dd]
66. Ncgc00018277-06
67. Ncgc00094900-01
68. Ncgc00094900-02
69. Ncgc00094900-03
70. 3,4-dimethoxybenzoic Acid 4-[ethyl[2-(4-methoxyphenyl)-1-methylethyl]amino]butyl Ester Hydrochloride
71. Veratric Acid, Butyl Ester, Hydrochloride
72. Db-047240
73. Ft-0603620
74. Mebeverine Hydrochloride, Analytical Standard
75. D04868
76. Mebeverine Hydrochloride [ep Monograph]
77. N16922
78. Wln: 1or Bo1 Dvo4n2&y1&1r Do1 &gh
79. 753m459
80. A819105
81. Sr-01000003159-4
82. W-109821
83. Mebeverine Hcl Pound>>csag-144 Pound>>csag 144 Pound>>csag144
84. 3,4-dimethoxybenzoicacid4-ethyl2-(4-methoxyphenyl)-1-methylethylaminobutylesterhydrochloride
85. 4-(ethyl(1-(4-methoxyphenyl)propan-2-yl)amino)butyl3,4-dimethoxybenzoatehydrochloride
86. Veratric Acid, 4-[ethyl(p-methoxy-.alpha.-methylphenethyl)amino]butyl Ester Hydrochloride
87. 3,4-dimethoxybenzoic Acid 4-[ethyl-[1-(4-methoxyphenyl)propan-2-yl]amino]butyl Ester Hydrochloride
88. Benzoic Acid,4-dimethoxy-, 4-[ethyl[2-(4-methoxyphenyl)-1-methylethyl]amino]butyl Ester, Hydrochloride
| Molecular Weight | 466.0 g/mol |
|---|---|
| Molecular Formula | C25H36ClNO5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 14 |
| Exact Mass | 465.2282009 g/mol |
| Monoisotopic Mass | 465.2282009 g/mol |
| Topological Polar Surface Area | 57.2 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 494 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
Anticonvulsants
Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)
Certificate Number : CEP 2021-271 - Rev 00
Status : Valid
Issue Date : 2023-09-25
Type : Chemical
Substance Number : 2097
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Certificate Number : CEP 2019-061 - Rev 03
Status : Valid
Issue Date : 2026-02-26
Type : Chemical
Substance Number : 2097
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Mebeverine Hydrochloride, Unit-II
Certificate Number : CEP 2022-476 - Rev 00
Status : Valid
Issue Date : 2025-08-29
Type : Chemical
Substance Number : 2097
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : CEP 2019-271 - Rev 04
Status : Valid
Issue Date : 2026-04-16
Type : Chemical
Substance Number : 2097

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : CEP 2022-002 - Rev 00
Status : Valid
Issue Date : 2024-03-13
Type : Chemical
Substance Number : 2097

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : CEP 2023-409 - Rev 00
Status : Valid
Issue Date : 2026-01-16
Type : Chemical
Substance Number : 2097

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : CEP 2024-278 - Rev 00
Status : Valid
Issue Date : 2025-11-26
Type : Chemical
Substance Number : 2097

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Cancelled
Registration Country : Spain
Brand Name : Mebeverina Aristo
Dosage Form : Film Coated Tablet
Dosage Strength : 135MG
Packaging :
Approval Date : 09-07-2020
Application Number : 85238
Regulatory Info : Cancelled
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Ukraine
Brand Name : Spark
Dosage Form : Capsule
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Ukraine

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorised
Registration Country : Malta
Brand Name : Medoverine
Dosage Form : Film Coated Tablet
Dosage Strength : 135MG
Packaging :
Approval Date : 2007-06-18
Application Number :
Regulatory Info : Authorised
Registration Country : Malta

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Withdrawn
Registration Country : Malta
Ispaghula Husks; Mebeverine Hydrochloride
Brand Name : Fybogel Mebeverine
Dosage Form : Granule For Oral Suspension
Dosage Strength : 3.5G; 135MG
Packaging :
Approval Date : 2006-04-24
Application Number :
Regulatory Info : Withdrawn
Registration Country : Malta

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Duspatalin
Dosage Form : Coated Tablet
Dosage Strength : 135MG
Packaging :
Approval Date : 01-04-1977
Application Number : 53900
Regulatory Info : Authorized
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Duspatalin Retard
Dosage Form : Prolonged-Release Capsules
Dosage Strength : 200mg
Packaging :
Approval Date : 20-06-2003
Application Number : 28103339102
Regulatory Info : Prescription
Registration Country : Denmark

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Generic
Registration Country : Turkey
Brand Name :
Dosage Form : PELLET RETARD CAPSULE
Dosage Strength : 200MG
Packaging : 30 Capsules
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Turkey

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Moldova
Brand Name : Duskonal retard
Dosage Form : Extended Release Capsule
Dosage Strength :
Packaging :
Approval Date : 25-07-2025
Application Number :
Regulatory Info :
Registration Country : Moldova

Regulatory Info : Withdrawn
Registration Country : Malta
Brand Name : Colofac Mr
Dosage Form : Prolonged-Release Hard Capsule
Dosage Strength : 200MG
Packaging :
Approval Date : 2018-09-05
Application Number :
Regulatory Info : Withdrawn
Registration Country : Malta

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : Withdrawn
Registration Country : Malta
Brand Name : Colofac
Dosage Form : Coated Tablet
Dosage Strength : 135MG
Packaging :
Approval Date : 2021-07-19
Application Number :
Regulatory Info : Withdrawn
Registration Country : Malta

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
18
PharmaCompass offers a list of Mebeverine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Mebeverine manufacturer or Mebeverine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mebeverine manufacturer or Mebeverine supplier.
A Duspatal manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Duspatal, including repackagers and relabelers. The FDA regulates Duspatal manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Duspatal API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Duspatal manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Duspatal supplier is an individual or a company that provides Duspatal active pharmaceutical ingredient (API) or Duspatal finished formulations upon request. The Duspatal suppliers may include Duspatal API manufacturers, exporters, distributors and traders.
click here to find a list of Duspatal suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Duspatal DMF (Drug Master File) is a document detailing the whole manufacturing process of Duspatal active pharmaceutical ingredient (API) in detail. Different forms of Duspatal DMFs exist exist since differing nations have different regulations, such as Duspatal USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Duspatal DMF submitted to regulatory agencies in the US is known as a USDMF. Duspatal USDMF includes data on Duspatal's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Duspatal USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Duspatal suppliers with USDMF on PharmaCompass.
A Duspatal CEP of the European Pharmacopoeia monograph is often referred to as a Duspatal Certificate of Suitability (COS). The purpose of a Duspatal CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Duspatal EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Duspatal to their clients by showing that a Duspatal CEP has been issued for it. The manufacturer submits a Duspatal CEP (COS) as part of the market authorization procedure, and it takes on the role of a Duspatal CEP holder for the record. Additionally, the data presented in the Duspatal CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Duspatal DMF.
A Duspatal CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Duspatal CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Duspatal suppliers with CEP (COS) on PharmaCompass.
A Duspatal written confirmation (Duspatal WC) is an official document issued by a regulatory agency to a Duspatal manufacturer, verifying that the manufacturing facility of a Duspatal active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Duspatal APIs or Duspatal finished pharmaceutical products to another nation, regulatory agencies frequently require a Duspatal WC (written confirmation) as part of the regulatory process.
click here to find a list of Duspatal suppliers with Written Confirmation (WC) on PharmaCompass.
Duspatal Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Duspatal GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Duspatal GMP manufacturer or Duspatal GMP API supplier for your needs.
A Duspatal CoA (Certificate of Analysis) is a formal document that attests to Duspatal's compliance with Duspatal specifications and serves as a tool for batch-level quality control.
Duspatal CoA mostly includes findings from lab analyses of a specific batch. For each Duspatal CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Duspatal may be tested according to a variety of international standards, such as European Pharmacopoeia (Duspatal EP), Duspatal JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Duspatal USP).